To evaluate combined mTORC1 and LSD1 inhibition, we next performed RNA sequencing of THP1 AML cells treated for 24 h with DMSO vehicle, OG-86 (250 nM), RAD001 (40 nM) or a combination of both. Here, KDM1A is linked to acute myeloid leukemia.